[donocco]

In 1999 a doctor named George Brewer did an experiment with copper reduction using a copper chelator called Ammonium Tetrathiomolybdate. He got a few very positive results and this was in advanced cancer patients of differing types of cancer.

Apparently the proteins involved in tumor blood vessel formation are dependent on copper ions, and if you can lower the patients serum copper to 20% of baseline you can halt tumor blood vessel formation (tumor angiogenesis) without much toxicity to the patient.

If this is correct, at least in theory, an oncologist could use copper reduction to prevent these stem cells from forming life
threatening mets. Once the tumor reaches a size of one million cells (about the size of the smallest dot you can make with your pencil) if it doesn't start producing blood vessels it cant grow much further. Keeping the patients copper level low might be very valuable in the long term treatment of cancer.
The patient's copper level would have to be carefully monitored by the oncologist because if it goes too low there can be anemia and neutropenia.

Paul